Bill & Melinda Gates Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 15, 2015
Pages: 32
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B097F8D5D2AEN
Leaflet:

Download PDF Leaflet

Bill & Melinda Gates Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Bill & Melinda Gates Foundation (BMGF) is a healthcare service provider. The company concentrates on improving healthcare, decrease poverty in America, widens learning opportunities and provides access to information equipment. It provides global health services such as discovery and translational sciences, enteric and diarrheal diseases, HIV, malaria, neglected infectious diseases, and tuberculosis services. BMGF’s global development services include agricultural development, emergency response, family planning, financial services for the poor, global libraries, integrated delivery, nutrition, vaccine delivery, and water, sanitation and hygiene services. The company has its presence in China, India, Africa, Europe and Middle East, and the US. BMGF is headquartered in Seattle, Washington, the US.

Bill & Melinda Gates Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Medical Devices Deals, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
CureVac to Raise USD76 Million in Venture Financing
Affinivax Raises USD4 Million in Seed Venture Financing
Synlogic Raises Additional USD5 Million in Series A Venture Financing
Kymab Raises USD40 Million in Series B Financing
Visterra Raises US$8.1 Million In Extended Series A Financing
Visterra Raises Additional US$13 Million In Series A Financing
Genocea Biosciences Raises US$30 Million In Series C Financing
Partnerships
CureVac to Enter into Development Agreement with Bill & Melinda Gates
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines
GSK Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines
Anacor Pharma Enters Into Research Agreement With Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Key Facts
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Deals By Therapy Area, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Medical Devices Deals, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
CureVac to Raise USD76 Million in Venture Financing
Affinivax Raises USD4 Million in Seed Venture Financing
Synlogic Raises Additional USD5 Million in Series A Venture Financing
Kymab Raises USD40 Million in Series B Financing
Visterra Raises US$8.1 Million In Extended Series A Financing
Visterra Raises Additional US$13 Million In Series A Financing
Genocea Biosciences Raises US$30 Million In Series C Financing
CureVac to Enter into Development Agreement with Bill & Melinda Gates
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines
GSK Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines
Anacor Pharma Enters Into Research Agreement With Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation, Key Competitors
Bill & Melinda Gates Foundation, Key Employees
Bill & Melinda Gates Foundation, Other Locations

LIST OF FIGURES
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Bill & Melinda Gates Foundation, Medical Devices Deals, 2009 to YTD 2015
Skip to top


Ask Your Question

Bill & Melinda Gates Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: